SCHEDULE OF CONCENTRATION RISK (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Customer A [Member] | Revenue Benchmark [Member] | Contract Services [Member]
Product Information [Line Items]
Concentration risk percentage		23.00%
Customer B [Member] | Revenue Benchmark [Member] | Regenerative Medicine [Member]
Product Information [Line Items]
Concentration risk percentage	13.00%
Customer B [Member] | Accounts Receivable [Member] | Regenerative Medicine [Member]
Product Information [Line Items]
Concentration risk percentage	14.00%	14.00%
Customer C [Member] | Revenue Benchmark [Member] | Contract Services [Member]
Product Information [Line Items]
Concentration risk percentage	41.00%
Customer C [Member] | Accounts Receivable [Member] | Contract Services [Member]
Product Information [Line Items]
Concentration risk percentage	46.00%
Customer D [Member] | Accounts Receivable [Member] | Contract Services [Member]
Product Information [Line Items]
Concentration risk percentage		15.00%
Customer D [Member] | Accounts Receivable [Member] | Regenerative Medicine [Member]
Product Information [Line Items]
Concentration risk percentage		11.00%